Echosens announced that its FibroScan device received clearance from the FDA.
FibroScan is used in the clinical management of patients with liver disease such as chronic viral hepatitis C and B and fatty liver diseases. Transient elastography enables FibroScan to assess liver shear wave speed (m/s) and equivalent stiffness (kPa) at 50Hz in a rapid and non-invasive way. The FibroScan device also explores a large volume that is about 100 times larger than the biopsy.
FibroScan is currently available in 70 countries.
For more information visit www.echosens.com.